WednesdayMar 25, 2020 9:22 am

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Reports Q4, Full Year 2019 Financial Results; Hosts Conference Call

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Tuesday reported its financial and operational results for the fourth quarter and full year ended December 31, 2019. Among other highlights, the company reported that revenue for the full year of 2019 totaled $402,000, and that $133,000, or 33% was earned in the fourth quarter. This compares to total revenue of $388,000 for the full year of 2018, of which $56,000 was earned in the fourth quarter of 2018. Sigma Labs’ Executive Chairman Mark Ruport, CEO John Rice and CFO Frank Orzechowski…

Continue Reading

TuesdayMar 24, 2020 2:51 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Subsidiary Launches New Agency/Broker Program

InsuraGuest Technologies (TSX.V: ISGI), under its wholly owned U.S. subsidiary InsuraGuest Insurance Agency, LLC (the “Agency”), this morning announced the successful launch of its Agency/Broker Program. The program is designed to concentrate on agencies and brokers that write general liability polices specifically for hotels and vacation rental properties. InsuraGuest’s Insurtech platform is adept at integrating with roughly 71 different hotel and vacation rental property management systems, granting it access to millions of rooms worldwide. “We have already signed up a major broker in Salt Lake City, Utah, and, due to demand, we are expanding our marketing efforts to include agents/brokers…

Continue Reading

TuesdayMar 24, 2020 1:23 pm

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Subsidiary Achieves Promising Results During First Week of Virtual Solar Sales

SinglePoint (OTCQB: SING) today announced that its Direct Solar America subsidiary has positioned the entire company for success as its first week of virtual sales demonstrated encouraging results. Per the release, SinglePoint has always intended on moving to an entirely online purchase system, and current conditions have acted as a catalyst to implement this vision now. In the first week, Direct Solar has closed multiple deals and is developing a pipeline of additional homeowners setting up new appointments. Direct Solar America is currently bringing on additional virtual agents. If you are interested in setting appointments or selling solar, call 844-830-1615.…

Continue Reading

TuesdayMar 24, 2020 10:20 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Strategic Board Appointments of Three Biotechnology and Healthcare Industry Leaders

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. The new appointments, which include Brent Longnecker, CEO of Longnecker & Associates, Jose A. Moreno Toscano, CEO of LFB USA Inc, and William R. (“Will”) Wilson, Jr., chairman, president and CEO of Wilson Land & Cattle Co., are designed to strengthen Genprex as it executes on its key clinical programs, continues to build its pipeline, and evaluates future license or corporate partnership agreements. “We are honored to have Brent,…

Continue Reading

TuesdayMar 24, 2020 10:06 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

Continue Reading

MondayMar 23, 2020 1:50 pm

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Commences Delivery of $3M to $5M of Rugged and In-Vehicle Push-to-Talk Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has commenced delivery on its large government tender for up to 15,000 push-to-talk devices, previously announced on December 02, 2019. According to the update, the majority of the order is anticipated to be delivered in Q1 and Q2 and the tender is valued between $3-million to $5-million, depending on the total units and mix between rugged handsets and in-vehicle devices. “Make no mistake, push-to-talk devices are mission critical solutions for public safety workers on the first line of defense; they are supported by dedicated cellular networks to improve communication, while…

Continue Reading

MondayMar 23, 2020 1:25 pm

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast Track Designation for its lead drug candidate, its newly licensed gene therapy for diabetes, and over $26 million capital raise that will support funding of its clinical programs. “We are delighted to welcome Catherine and Michael to our executive leadership team. They join us at…

Continue Reading

MondayMar 23, 2020 12:55 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

Continue Reading

MondayMar 23, 2020 12:27 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.5 Million in Private Placement

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced its March 19, 2020, closing on its previously announced private offering of common stock and warrants resulting in gross proceeds of $3,498,612 to the Company. Per the offering, the Company sold and issued 1,650,166 shares of common stock (or common stock equivalents) and issued Series A warrants to acquire 1,650,166 shares of Common Stock at $1.88 per share, exercisable immediately and terminating five and one-half years after the date of…

Continue Reading

MondayMar 23, 2020 11:51 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://ibn.fm/5ILIz About Lexaria Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered